Answers are grounded in this paper and cite their sources.
OPMDs, especially Erosive lichen planus, oral submucous fibrosis, and nonhomogeneous leukoplakia, show an increased tendency for malignant transformation. This increased rate of malignant transformation might be due to the generation of free radicals, which induce cell mutation. These free radicals are countered by systemic antioxidants. Due to the lack of absorption at the site where it is needed, there is a need for the topical route of administration. It is predicted that 20% of the systemic antioxidant is taken into action at the particular site of the oral cavity. So, there is a need for the topical route of administration to achieve the complete degeneration of free radicals. The study aims to formulate the Acorus calamus nano-emulsion and check for antioxidant properties. The main objective of the current study is to formulate the nano-emulsion of the Acorus calamus and check for the antioxidant properties by DPPH and ABTS assays. The nano-emulsion was prepared by mixing 10 mg of powder with an oil-in-water emulsion containing 10 mL of water, 60 mL of palm oil, and 30 mL of Tween 20. Further, the mixture was sonicated for 60 min, and the milky white formation indicates the emulsion formation. With the increase in the volume of the nanoemulsion of the Acorus calamus, the particle size distribution also increases to 250 nm when the volume reaches 100%, and then it gradually decreases to 450 nm. Acorus calamus nano-emulsion has antioxidant properties by inhibiting the action of free radicals. Nano-emulsion of the Acorus calamus has higher penetration when the size is less than 100 microns into the human epithelial cells. Therefore, it is more useful in the management of OPMDs when applied topically.
No takes yet. Share an insight, caveat, or question.
V et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: